New! Search for patents from more than 100 countries including Australia, Brazil, Sweden and more

GB9711990D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB9711990D0
GB9711990D0 GBGB9711990.3A GB9711990A GB9711990D0 GB 9711990 D0 GB9711990 D0 GB 9711990D0 GB 9711990 A GB9711990 A GB 9711990A GB 9711990 D0 GB9711990 D0 GB 9711990D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9711990.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB9711990.3A priority Critical patent/GB9711990D0/en
Publication of GB9711990D0 publication Critical patent/GB9711990D0/en
Application status is Pending legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/38Medical treatment of vector-borne diseases characterised by the agent
    • Y02A50/408Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a protozoa
    • Y02A50/411Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a protozoa of the genus Plasmodium, i.e. Malaria
    • Y02A50/412Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a protozoa of the genus Plasmodium, i.e. Malaria the medicinal preparation containing antigens or antibodies, e.g. vaccines, antisera
GBGB9711990.3A 1997-06-11 1997-06-11 Vaccine Pending GB9711990D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9711990.3A GB9711990D0 (en) 1997-06-11 1997-06-11 Vaccine

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
GBGB9711990.3A GB9711990D0 (en) 1997-06-11 1997-06-11 Vaccine
KR1019997011655A KR20010013644A (en) 1997-06-11 1998-06-03 Oil in water vaccine compositions
IL13312698A IL133126D0 (en) 1997-06-11 1998-06-03 Oil in water vaccine compositions
BR9810614-7A BR9810614A (en) 1997-06-11 1998-06-03 Compositions of oil-in-water vaccines
PCT/EP1998/003479 WO1998056414A1 (en) 1997-06-11 1998-06-03 Oil in water vaccine compositions
HU0004001A HU0004001A3 (en) 1997-06-11 1998-06-03 Oil in water vaccine compositions
CN98806134A CN1260723A (en) 1997-06-11 1998-06-03 Oil in water vaccine composition
CA002293444A CA2293444A1 (en) 1997-06-11 1998-06-03 Oil in water vaccine compositions
PL98337488A PL337488A1 (en) 1997-06-11 1998-06-03 Oil-in-water type compositions for vaccines
JP50158899A JP2002504106A (en) 1997-06-11 1998-06-03 Oil-in-water vaccine composition
EP98933600A EP0999852A1 (en) 1997-06-11 1998-06-03 Oil in water vaccine compositions
AU83365/98A AU728759B2 (en) 1997-06-11 1998-06-03 Oil in water vaccine compositions
TR1999/03048T TR199903048T2 (en) 1997-06-11 1998-06-03 fatty vaccine composition in water
CO98032854A CO4940401A1 (en) 1997-06-11 1998-06-09 vaccines
ZA9804969A ZA9804969B (en) 1997-06-11 1998-06-09 Vaccine.
ARP980102741A AR012959A1 (en) 1997-06-11 1998-06-10 Adjuvant compositions for vaccines, vaccine compositions including such adjuvant compositions, process for making dichasvacunas, the use of such adjuvant compositions in the manufacture of medicaments and process for stabilizing emulsions water-in-oil
NO996133A NO996133A (en) 1997-06-11 1999-12-10 Oil-in-water vaccine formulations

Publications (1)

Publication Number Publication Date
GB9711990D0 true GB9711990D0 (en) 1997-08-06

Family

ID=10813866

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9711990.3A Pending GB9711990D0 (en) 1997-06-11 1997-06-11 Vaccine

Country Status (17)

Country Link
EP (1) EP0999852A1 (en)
JP (1) JP2002504106A (en)
KR (1) KR20010013644A (en)
CN (1) CN1260723A (en)
AR (1) AR012959A1 (en)
AU (1) AU728759B2 (en)
BR (1) BR9810614A (en)
CA (1) CA2293444A1 (en)
CO (1) CO4940401A1 (en)
GB (1) GB9711990D0 (en)
HU (1) HU0004001A3 (en)
IL (1) IL133126D0 (en)
NO (1) NO996133A (en)
PL (1) PL337488A1 (en)
TR (1) TR199903048T2 (en)
WO (1) WO1998056414A1 (en)
ZA (1) ZA9804969B (en)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225289B1 (en) 1998-12-10 2001-05-01 Genvec, Inc. Methods and compositions for preserving adenoviral vectors
PT1154790E (en) * 1999-02-26 2005-03-31 Chiron Srl Strengthening the bactericidal activity against Neisseria antigens containing CG motifs with oligonucleotides
US6558670B1 (en) 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
CN1227030C (en) 1999-04-19 2005-11-16 史密丝克莱恩比彻姆生物有限公司 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
ES2392943T3 (en) 2000-10-18 2012-12-17 Glaxosmithkline Biologicals S.A. antitumor vaccines
AU781469B2 (en) * 1999-05-13 2005-05-26 Wyeth Holdings Corporation Adjuvant combination formulations
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US8017590B1 (en) 1999-10-22 2011-09-13 Sanofi Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
AT513913T (en) 2000-05-10 2011-07-15 Sanofi Pasteur Ltd By mage mini gene encoded immunogenic polypeptide and its uses
TWI228420B (en) * 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
CN1555253A (en) * 2001-09-13 2004-12-15 韩国科学技术研究院 Oily composition of taxol,preparation for chemical therapeutic embolism and their producing method
US20050250175A1 (en) * 2002-08-02 2005-11-10 Takehiko Nomura Bacterial cell wall skeleton component preparaion
ES2594758T3 (en) 2002-10-23 2016-12-22 Glaxosmithkline Biologicals S.A. Vaccination procedures against malaria
JP2008500984A (en) 2004-05-28 2008-01-17 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Vaccine composition comprising virosomes and a saponin adjuvant
GB0417494D0 (en) 2004-08-05 2004-09-08 Glaxosmithkline Biolog Sa Vaccine
WO2006100111A1 (en) 2005-03-23 2006-09-28 Glaxosmithkline Biologicals S.A. Composition
GB0513421D0 (en) 2005-06-30 2005-08-03 Glaxosmithkline Biolog Sa Vaccines
GB0522765D0 (en) 2005-11-08 2005-12-14 Chiron Srl Combination vaccine manufacture
KR101367237B1 (en) 2005-12-22 2014-03-14 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
US20100021503A1 (en) 2006-03-30 2010-01-28 Glaxosmithkline Biologicals S.A. Immunogenic composition
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US9839685B2 (en) 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
EA200900024A1 (en) 2006-07-17 2009-06-30 Глаксосмитклайн Байолоджикалс С.А. influenza vaccine
NZ574238A (en) 2006-07-18 2012-02-24 Glaxosmithkline Biolog Sa Vaccines for malaria
WO2008012538A2 (en) 2006-07-25 2008-01-31 The Secretary Of State For Defence Live vaccine strains of francisella
HUE037808T2 (en) 2006-09-26 2018-09-28 Infectious Disease Res Institute Vaccine composition containing synthetic adjuvant
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
PE01462009A1 (en) 2007-04-20 2009-03-23 Glaxosmithkline Biolog Sa immunogenic composition against influenza virus
KR101192127B1 (en) 2006-11-03 2012-10-17 쉐링-프라우 리미티드 Canine lyme disease vaccine
SG194360A1 (en) 2007-03-02 2013-11-29 Glaxosmithkline Biolog Sa Novel method and compositions
CN101784282B (en) 2007-06-26 2015-07-08 葛兰素史密丝克莱恩生物有限公司 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
WO2009021931A1 (en) 2007-08-13 2009-02-19 Glaxosmithkline Biologicals S.A. Vaccines
ES2626634T3 (en) 2007-12-19 2017-07-25 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Soluble forms of the virus F glycoprotein Hendra and Nipah and uses thereof
EP2293813A4 (en) 2008-05-23 2012-07-11 Univ Michigan Nanoemulsion vaccines
GB0815872D0 (en) 2008-09-01 2008-10-08 Pasteur Institut Novel method and compositions
JP5722782B2 (en) 2008-09-26 2015-05-27 ナノバイオ コーポレーション Nanoemulsion therapeutic compositions and methods of use thereof
GB0901411D0 (en) 2009-01-29 2009-03-11 Secr Defence Treatment
GB0901423D0 (en) 2009-01-29 2009-03-11 Secr Defence Treatment
EP2396032B1 (en) 2009-02-10 2016-09-28 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene
GB0906234D0 (en) 2009-04-14 2009-05-20 Secr Defence Vaccine
US8668911B2 (en) 2009-05-14 2014-03-11 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
EP3124491A1 (en) 2009-06-05 2017-02-01 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them
WO2010148111A1 (en) 2009-06-16 2010-12-23 The Regents Of The University Of Michigan Nanoemulsion vaccines
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0919117D0 (en) 2009-10-30 2009-12-16 Glaxosmithkline Biolog Sa Process
DE102009056883B4 (en) * 2009-12-03 2012-08-16 Novartis Ag Vaccine adjuvants and to improved processes for the preparation thereof
EP2353609A1 (en) 2010-02-04 2011-08-10 Sanofi Pasteur Immunization compositions and methods
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
AU2011231574A1 (en) 2010-03-26 2012-10-11 Glaxosmithkline Biologicals S.A. HIV vaccine
US8658603B2 (en) 2010-06-16 2014-02-25 The Regents Of The University Of Michigan Compositions and methods for inducing an immune response
BR112013007308A2 (en) 2010-09-27 2016-07-05 Glaxosmithkline Biolog Sa vaccine
BR112013004582A2 (en) 2010-09-27 2016-09-06 Crucell Holland Bv method for inducing an immune response in a subject against an antigen of a parasite that causes malaria
GB201022007D0 (en) 2010-12-24 2011-02-02 Imp Innovations Ltd DNA-sensor
CN103347892B (en) 2011-01-06 2016-11-02 比奥诺尔免疫有限公司 Monomeric and polymeric immunogenic peptide
EA027236B1 (en) 2011-04-08 2017-07-31 Иммьюн Дизайн Корп. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
CA2848611A1 (en) 2011-09-16 2013-03-21 Ucb Pharma S.A. Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile
WO2013074501A1 (en) 2011-11-14 2013-05-23 Crucell Holland B.V. Heterologous prime-boost immunization using measles virus-based vaccines
EP2788477A2 (en) 2011-12-07 2014-10-15 Institut Pasteur Identification of a swine parecho-like virus and applications
LT2850431T (en) 2012-05-16 2018-06-25 Immune Design Corp. Vaccines for hsv-2
EA201492262A1 (en) 2012-06-06 2015-08-31 Бионор Иммуно Ас The design of peptide backbone
EP2877208A1 (en) 2012-07-24 2015-06-03 Sanofi Pasteur Vaccine compositions
PE03562015A1 (en) 2012-07-24 2015-03-20 Sanofi Pasteur Vaccine compositions for the prevention against infection by dengue virus
WO2014083194A1 (en) 2012-11-30 2014-06-05 Sanofi Pasteur Methods for inducing antibodies
CN105209047A (en) 2013-04-18 2015-12-30 免疫设计股份有限公司 GLA monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
US20160280763A1 (en) 2013-11-01 2016-09-29 University Of Oslo Albumin variants and uses thereof
WO2015071769A2 (en) 2013-11-13 2015-05-21 University Of Oslo Outer membrane vesicles and uses thereof
EP3069138B1 (en) 2013-11-15 2019-01-09 Oslo Universitetssykehus HF Ctl peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
US20160287696A1 (en) 2013-11-20 2016-10-06 La Jolla Institute For Allergy And Immunology Pan pollen immunogens and methods and uses for immune response modulation
WO2015092710A1 (en) 2013-12-19 2015-06-25 Glaxosmithkline Biologicals, S.A. Contralateral co-administration of vaccines
CA2935722A1 (en) 2014-01-21 2015-07-30 Immune Design Corp. Compositions for use in the treatment of allergic conditions
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
KR101696514B1 (en) * 2014-08-18 2017-01-24 서울대학교산학협력단 Temperature Sensitive Mycobacterial strain and its use as vaccine against mycobacterial infection disease
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
WO2017158421A1 (en) 2016-03-14 2017-09-21 University Of Oslo Anti-viral engineered immunoglobulins
CA3011887A1 (en) 2016-03-14 2017-09-21 Stian FOSS Engineered immunoglobulins with altered fcrn binding
WO2017221072A2 (en) 2016-06-21 2017-12-28 University Of Oslo Hla binding vaccine moieties and uses thereof
WO2018037045A1 (en) 2016-08-23 2018-03-01 Glaxosmithkline Biologicals Sa Fusion peptides with antigens linked to short fragments of invariant chain (cd74)
WO2018060288A1 (en) 2016-09-29 2018-04-05 Glaxosmithkline Biologicals S.A. Compositions and methods of treatment of persistent hpv infection
WO2018096396A1 (en) 2016-11-22 2018-05-31 University Of Oslo Albumin variants and uses thereof
GB201620968D0 (en) 2016-12-09 2017-01-25 Glaxosmithkline Biologicals Sa Adenovirus polynucleotides and polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
IL133126D0 (en) 2001-03-19
CA2293444A1 (en) 1998-12-17
EP0999852A1 (en) 2000-05-17
JP2002504106A (en) 2002-02-05
HU0004001A2 (en) 2001-03-28
AR012959A1 (en) 2000-11-22
PL337488A1 (en) 2000-08-28
AU8336598A (en) 1998-12-30
BR9810614A (en) 2000-09-12
CN1260723A (en) 2000-07-19
KR20010013644A (en) 2001-02-26
AU728759B2 (en) 2001-01-18
CO4940401A1 (en) 2000-07-24
NO996133A (en) 2000-01-26
WO1998056414A1 (en) 1998-12-17
TR199903048T2 (en) 2000-08-21
HU0004001A3 (en) 2001-07-30
ZA9804969B (en) 1999-12-09
NO996133D0 (en) 1999-12-10

Similar Documents

Publication Publication Date Title
DE69810944D1 (en) Hydroperoxidzersetzungsverfahren
DE69804606D1 (en) Cyclohexandiolderivate
DE69838100D1 (en) Gefässprothese
DE69829970D1 (en) Implantsystem
DE59809032D1 (en) Telephonsystem
DE69817801D1 (en) Arylsulfonylhydroxamsäurederivate
DE69735266D1 (en) Substituierte naphthopyrane
DE59811113D1 (en) Laryngoskop
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
DE69807872D1 (en) Thermoplastisches polyetherurethan
DE69824410D1 (en) Antithrombosemittel
GB2330196B (en) Starcloth
DE69825167D1 (en) Quenchkühler
DE69801682D1 (en) Versteifte trimethin-cyaninfarbstoffe
DE69818810D1 (en) Heteroligand
DE69831868D1 (en) Antithrombosemittel
DE59803915D1 (en) Bandwaage
DE69737400D1 (en) Substituierte naphthopyrane
DE69824433D1 (en) Proteintyrosinphosphatase inhibitoren
DE69840917D1 (en) Bandzentriervorrichtung
DE69813225D1 (en) Blockcopolymere
DE59804066D1 (en) Triazolinthion-phosphorsäure-derivate
DE69829380D1 (en) Klampe
DE69818261D1 (en) Hydroxycyclopentanone
DE69831010D1 (en) Knöchel-fuss orthese